AstraZeneca makes progress with Truqap and Enhertu cancer treatments
(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering. Read More